CLINICAL_TRIALS
trial_result
· 2016-01-01
Clinical Trial Update: Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides [Phase 4]
Summary
Phase 4 clinical trial update on adding pegylated interferon alfa-2a to chronic hepatitis B patients already treated with nucleos(t)ide analogs.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Hepatitis B | Phase 4 | Status: UNKNOWN